FDA 483 - Solomon Park Research Laboratories - January 08, 2026

An FDA inspection of Solomon Park Research Laboratories, Inc. in Burien, WA, revealed significant deficiencies in their quality system. The firm lacked written procedures for Medical Device Reporting and the disposition of nonconforming products. Additionally, their medical devices did not bear unique device identifiers (UDI) as required by regulations.